Skip to content
Search

Latest Stories

RPS calls on political leaders to end prescription charges for long-term conditions

RPS calls on political leaders to end prescription charges for long-term conditions
RPS and PCC urge political leaders to urgently get rid of prescription charges for chronic conditions on the currently outdated exemption list

In partnership with the Prescription Charges Coalition (PCC), the Royal Pharmaceutical Society (RPS) has taken a significant step by urging political leaders to abolish prescription charges for individuals with long-term conditions.

Tase Oputu, Chair of the RPS England Pharmacy Board, signed an open letter on Thursday, calling on party leaders to address this pressing issue.


The letter emphasises the outdated nature of the current exemption list, which forces individuals with chronic conditions like Parkinson’s, cystic fibrosis, and HIV to bear the cost of their essential medications.

It urges party leaders to urgently review and update the exemption list to ensure equitable access to necessary medicines.

“Nobody should face a financial barrier to accessing the medicines they need," Oputu stated.

"Prescription charges are a stealth tax on health, and every day pharmacists are asked by patients who are unable to afford all the items in their prescription which ones they could 'do without'."

She further highlighted the adverse effects of this financial burden on patients’ health and the broader healthcare system.

“If you can’t afford your medicines, your condition can worsen, leading to poor health, lost productivity, and increased risk of hospital admission, piling pressure on the NHS.

"As the general election approaches, I hope that political parties can commit to scrapping this complex and unjust system,” she added.

Need to revise outdated exemption list

The PCC’s letter to the Conservative and Labour party leaders underscores the urgency of reviewing the exemption list.

It draws attention to the unfairness of the current system, which leaves people with various chronic conditions paying for vital medications necessary for their well-being.

Earlier this week, the Liberal Democrats committed to reviewing the exemption list if elected, as outlined in their manifesto released on June 10th.

This commitment by the Lib Dems has added momentum to the coalition's campaign, with the hope that other parties will follow suit.

The letter, signed by over 20 members of the PCC, sets a compelling case for the new government to revise the outdated exemption list.

The exemption list currently affects individuals with asthma, sickle cell, HIV, cystic fibrosis, Parkinson’s, Crohn’s, and colitis, as well as heart, lung, and kidney diseases.

As the general election draws near, the RPS and PCC are encouraging voters to engage with their local election candidates.

They are urging them to commit to reviewing the prescription exemption list and ensuring that those with long-term conditions receive the necessary medications without financial strain.

The RPS’s call for action highlights a critical public health issue that demands immediate attention from political leaders.

The coalition awaits responses from the party leaders, hopeful for a commitment to end prescription charges and promote equitable healthcare access.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less